Megan Rice is an Associate Principal Scientist at AstraZeneca, where they lead the development of a dual-payload antibody-drug conjugate platform utilizing proprietary non-natural amino acid technology. Previously, they served as a Senior Scientist, co-leading pre-clinical ADC projects within AstraZeneca's oncology portfolio. Their earlier experience includes roles as an R&D Associate II at MedImmune, specializing in cancer-targeting biologics, and as a Research Assistant at the University of Massachusetts Amherst, where they mapped metabolic pathways in C. phytofermentans. They hold a Master of Science in Microbiology from the University of Massachusetts Amherst and a Bachelor of Science in Biology from SUNY Potsdam.
This person is not in the org chart
This person is not in any teams
This person is not in any offices